Real-world outcomes with different technology modalities in type 1 diabetes

Several treatment modalities are available for type 1 diabetes (T1D), including continuous glucose monitoring (CGM) and flash glucose monitoring (FGM) with MDI, sensor-augmented pumps with predictive low-glucose suspend function (SAP-PLGS) and hybrid closed-loop systems (HCL). The aim of the study was to evaluate the real-world benefits obtained with these treatment modalities.

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - March 2, 2021 Category: Nutrition Authors: Pilar Isabel Beato-V íbora, Fabiola Gallego-Gamero, Ana Ambrojo-López Source Type: research